Developing new anti-cancer drugs that are effective in diverse populations | YC S21
Yemaachi Biotech is a pioneering biotechnology research company dedicated to cancer innovation, with a focus on developing effective anti-cancer drugs for diverse populations. Yemaachi Biotech leverages cutting-edge technologies, including molecular diagnostics, artificial intelligence, immunology, bioinformatics, and next-generation sequencing, to advance its research and development efforts.
Yemaachi Biotech operates with a global perspective, driving advancements from its headquarters at Primary: 222 Swaniker Street, Abelemkpe, Accra, GH, and extending its reach through locations at APHRC Campus, Kitisuru, Nairobi, KE, and 1250 Connecticut Ave NW, Suite 700, Washington, District of Columbia 20036, US. Yemaachi Biotech is committed to shaping the future of cancer treatment through innovative and impactful research.
With a strong foundation in biotechnology and a commitment to global health, Yemaachi Biotech is poised for continued growth and success. We invite the management of Yemaachi Biotech to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.
Compare Yemaachi Biotech with 3 companies in Biotechnology-Research
| Comparison Field |
Yemaachi BiotechMain Company |
GeneDxView Profile |
Arsenal Biosciences,...View Profile |
Ve
Verdant AIView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2019 | 2018 |
|
Company Size
|
— | 1,001-5,000 | 201-500 | 2-10 |
|
City
|
Stamford, CT | South San Francisco , CA | Los Angeles, CA | |
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Biotechnology
Cancer Research
Drug Development
Molecular Diagnostics
Artificial Intelligence
Immunology
Bioinformatics
molecular diagnostics
artificial intelligence
immunology
bioinformatics
next generation sequencing
|
8 Total
8 Unique
Unique Skills:
exome
genetic testing
genetics
genome
neonatal screening
rare genetic disorders
+2
|
5 Total
1 Common
4 Unique
Match
8%
Common Skills:
Biotechnology
Unique Skills:
cancer
cell therapy
machine learning
technology
|
3 Total
3 Unique
Unique Skills:
big data
cybernetics
high performance computing
|
Other organizations in the same industry
This company is also known as